Research and Development

1. Synopsis of R&D Pipeline and Agreement Status

2. Drug Discovery

3. Natural Products

4. Traditional Chinese Medicines (“TCM”)

5. Cell systems

6. Phytopharmaceuticals today

7. Patent strategy and Technology

8. Development strategy

9. Anti-cancer products: TriptoSar and other candidates

10. Immune Suppression Products: WilGraf and other candidates

11. Pulmonary Fibrosis: WilVent

12. Neuroprotective Agents: NeuroTriptin

13. Controlling PG490 Supply

14. Cytomegalovirus Infection: PG36

15. Hematopoiesis product: PG2

16. Hematopoiesis product: PG2-2000

17. B50 as Next Lead Candidate for hematopoiesis

18. Collaborative relationships

19. Future Discovery

20. Selected Publications

[ Pipeline ] [ Research ] [ Development ] [ New Areas ] [ PG490 Supply ] [ PG2 ] [ PG2-2000 ] [ B50 ] [ PG36 ] [ Collaborations ] [ Discovery ] [ Publications ]

[ Management ] [ R&D ] [ IP ] [ Contact ] [ Site Map ]

[ Home ]